Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OmniAb Inc OABI

Healthcare Biotechnology
OmniAb, Inc. offers a discovery platform that provides pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable the discovery of next-generation therapeutics. The OmniAb platform is the biological intelligence (BI) of transgenic animals, including OmniRat, OmniChicken, and OmniMouse, which have been genetically modified to... see more

Recent & Breaking News (NDAQ:OABI)

Ligand Reports Second Quarter 2022 Financial Results

Business Wire August 8, 2022

Ligand Reports First Quarter 2022 Financial Results

Business Wire May 4, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates NLSN, LHCG, AHPA

PR Newswire March 30, 2022

Moore Kuehn Encourages PLAN, HBP, Y, And AHPA Investors To Contact Law Firm

PR Newswire March 29, 2022

SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates EMCF, RNER, PV, AHPA

PR Newswire March 24, 2022

Ligand to Spin-Off its OmniAb Business Through Merger with Avista Public Acquisition Corp. II

Business Wire March 23, 2022